638
Views
15
CrossRef citations to date
0
Altmetric
Articles

Hairy cell leukemia: epidemiology, pharmacokinetics of cladribine, and long-term follow-up of subcutaneous therapy

, &
Pages 46-49 | Published online: 23 May 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gunnar Juliusson, Tamar Tadmor & Aaron Polliack. (2011) ‘Hairy’ cells: where are the roots of this leukemia?. Leukemia & Lymphoma 52:12, pages 2205-2206.
Read now

Articles from other publishers (14)

Sarah M Clark, Farmin Samareh-Jahani & Munir A Chaudhuri. (2020) Massive Splenomegaly and Pancytopenia: It’s a Hairy Situation. Cureus.
Crossref
Nilima Parry‐Jones, Anurag Joshi, Francesco Forconi & Claire Dearden. (2020) Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL‐V). British Journal of Haematology 191:5, pages 730-737.
Crossref
Rudolf Benz, Kornelius ArnMartin Andres, Thomas PabstMichael BaumannUrban Novak, Felicitas HitzUrs HessReinhard ZenhaeusernYves Chalandon, Ulrich MeySabine Blum, Daniel RauchAlix O'Meara SternNathan CantoniMario BargetziElena Bianchi-PapinaDavide RossiJakob Passweg, Andreas LohriSimona Berardi, Qiyu Li, Anita Feller & Georg Stussi. (2020) Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood Advances 4:15, pages 3699-3707.
Crossref
Matthew Cross & Claire Dearden. (2020) Hairy Cell Leukaemia. Current Oncology Reports 22:5.
Crossref
B. Wörmann. (2020) HaarzellleukämieHairy cell leukemia. Der Onkologe 26:3, pages 254-260.
Crossref
Marco Rabuffetti, Teodora Bavaro, Riccardo Semproli, Giulia Cattaneo, Michela Massone, Carlo F. Morelli, Giovanna Speranza & Daniela Ubiali. (2019) Synthesis of Ribavirin, Tecadenoson, and Cladribine by Enzymatic Transglycosylation. Catalysts 9:4, pages 355.
Crossref
Chaonan Ye, Kun Han, Jinxiu Lei, Kui Zeng, Su Zeng, Haixing Ju & Lushan Yu. (2018) Inhibition of histone deacetylase 7 reverses concentrative nucleoside transporter 2 repression in colorectal cancer by up-regulating histone acetylation state. British Journal of Pharmacology 175:22, pages 4209-4217.
Crossref
Michael R. GreverOmar Abdel-WahabLeslie A. AndritsosVersha BanerjiJacqueline BarrientosJames S. BlachlyTimothy G. CallDaniel CatovskyClaire DeardenJudit DemeterMonica ElseFrancesco ForconiAlessandro GozzettiAnthony D. HoJames B. JohnstonJeffrey JonesGunnar JuliussonEric KrautRobert J. KreitmanLoree LarrattFrancesco LauriaGerard LozanskiEmili MontserratSameer A. ParikhJae H. ParkAaron PolliackGraeme R. QuestKanti R. RaiFarhad RavandiTadeusz RobakAlan SavenJohn F. SeymourTamar TadmorMartin S. TallmanConstantine TamEnrico TiacciXavier TroussardClive S. ZentThorsten Zenz, Pier Luigi Zinzani & Brunangelo Falini. (2017) Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood 129:5, pages 553-560.
Crossref
Leslie A. Andritsos & Michael R. Grever. (2015) Historical overview of hairy cell leukemia. Best Practice & Research Clinical Haematology 28:4, pages 166-174.
Crossref
Tamar Tadmor & Aaron Polliack. (2015) Epidemiology and environmental risk in hairy cell leukemia. Best Practice & Research Clinical Haematology 28:4, pages 175-179.
Crossref
Monica Else, Claire E. Dearden & Daniel Catovsky. (2015) Long-term follow-up after purine analogue therapy in hairy cell leukaemia. Best Practice & Research Clinical Haematology 28:4, pages 217-229.
Crossref
Oscar Duems-Noriega & Sergio Ariño-Blasco. (2015) Subcutaneous fluid and drug delivery: safe, efficient and inexpensive. Reviews in Clinical Gerontology 25:2, pages 117-146.
Crossref
Pier Luigi Zinzani, Vittorio Stefoni, Alessandro Broccoli, Cinzia Pellegrini, Letizia Gandolfi, Beatrice Casadei, Roberto Maglie, Stefano Pileri & Lisa Argnani. (2014) Is it really possible to cure hairy cell leukemia patients only with frontline therapy?. Annals of Hematology 93:9, pages 1565-1569.
Crossref
V Maevis, U Mey, G Schmidt-Wolf & I G H Schmidt-Wolf. (2014) Hairy cell leukemia: short review, today’s recommendations and outlook. Blood Cancer Journal 4:2, pages e184-e184.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.